The Case for Compliance Monitoring

In partnering with Braebon, SomnoMed now has the first FDA approved mandibular advancement device in the US that has the capability to objectively monitor the number of hours that the patient uses the device over several months. While there has been an overwhelmingly positive reception to this development, I have come across some rare skepticsContinue